SlimLine Self-Dilating Autoclavable Operating Semi-Rigid Ureteroscope

Angled insertion forcep used for the Hydroview lens. Manufactured in titanium.

Biconvex jaw design. 40 degree angled shafts. Tip to angle length: 7.5 mm. Locking handle. Manufacturing in titanium.

Titanium. Designed to easily fold the hydroview lens. Will also fold many styles of soft intraocular lenses. Unique cross-action design facilitates folding of the lens.

Curved shafts with serrated 1.5 mm upper and 2 mm lower jaws. Serrated cross action handle with slide lock and polished finish. Most popular size or model.

(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....

(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...

(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...

(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...

...ropriate weight, according to current guidelines,/...nadequate weight to have a baby who becomes overwe... new study at the Department of Ambulatory Care an...d Pilgrim Health Care and are published in the Apr...

...y signs of cervical cancer and providing //prevent..., acceptable to women and feasible, according to a...School of Medicine. If this technique can be sca...vent one of the leading causes of cancer death in ...

... effects of antioxidants such as vitamin C.// Scie...the presence of lipid the ability of antioxidants,...tamin C), to protect against the generation of pot... less than when no lipids are present. “Our result...

...own and dirty say researchers from Bristol Univers...y led by Dr. Chris Lowry and team, claims that t...ccae, can actually replicate the effects of anti- ...sprung from reports of lung cancer patients who w...

(Date:9/3/2008)... September is National Vascular Disease Awareness ... -- Diffusion Pharmaceuticals,LLC, a clinical-stag...gs,for the treatment of unmet medical needs, annou... a Phase I/II clinical trial of its lead drug,cand...esignated NCT00725881,on the clinicaltrials.gov We...

(Date:9/3/2008)...RSBURG, Md., Sept. 3 /- Panacea Pharm....S. Patent Number 7,413,737 covering,antibodies ag...e (HAAH), a,proprietary human cancer biomarker and...ed in collaboration with the Massachusetts Institu...worldwide rights to this patent,for development of...

(Date:9/3/2008)... Company to Discuss Phase 3 Plans with FDA, ...erapeutics, Inc.,announced today that it successf...lopment of the company,s new, innovative low-dose,...ny refers to by its internal product,code AG-200-1...ully met its,primary endpoint of ovulation suppres...

(Date:9/3/2008)...nical Trial Reconfirms Strong Evidence Pycnogenol(...ing Effect on Joints Following Cessation ... Sept. 3 /- According to the Center f... common type of arthritis,is on the rise. A new s...py,Research, reveals Pycnogenol(R), bark extract f...

...ne 04, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosci... a Phase 2,monotherapy trial showing that tanespim...ity in patients with metastatic melanoma,includin... failed,prior chemotherapy (within 6 weeks of init...gression-free survival for more than,six months an...

...ne 04, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosci...linical,trial showing that KOS-1584/R1645, an epot...ed promising antitumor,activity and tolerability i...d activity in 32% of patients (13 of 41,evaluable)...l lung,ovarian, breast, prostate, head and neck a...